759
Views
59
CrossRef citations to date
0
Altmetric
Review

Pulmonary Rehabilitation in a Post-COVID-19 World: Telerehabilitation as a New Standard in Patients with COPD

, ORCID Icon & ORCID Icon
Pages 379-391 | Published online: 19 Feb 2021

References

  • Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68–78. doi:10.1161/CIRCULATIONAHA.120.047549
  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
  • Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91–98. doi:10.1016/j.jare.2020.03.005
  • Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742. doi:10.1016/j.antiviral.2020.104742
  • Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–224. doi:10.1038/s41586-020-2179-y
  • Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451–2460. doi:10.1056/NEJMcp2009575
  • Chen LYC, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome. Eur Respir J. 2020;56(4):2003006. doi:10.1183/13993003.03006-2020
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
  • Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.0233147
  • Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020
  • Attaway AA, Zein J, Hatipoglu US. SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: an analysis of Cleveland clinic’s COVID-19 registry. EClinicalMedicine. 2020;26:100515. doi:10.1016/j.eclinm.2020.100515
  • Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345–1355. doi:10.1001/jamainternmed.2020.3539
  • Calmes D, Graff S, Maes N, et al. Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV2 infection. J Allergy Clin Immunol Pract. 2021;9(1):160–169. doi:10.1016/j.jaip.2020.09.044
  • Leung JM, Niikura M, Yang CWT, et al. COVID-19 and COPD. Eur Respir J. 2020;56(2):2002108. doi:10.1183/13993003.02108-2020
  • Thomas M, Decramer M, O’Donnell DE. No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J. 2013;22(1):101–111. doi:10.4104/pcrj.2013.00025
  • Leung JM, Yang CX, Tam A, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020;55(5):2000688. doi:10.1183/13993003.00688-2020
  • Milne S, Yang CX, Timens W, et al. SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors. Lancet Respir Med. 2020;8(6):e50–e1. doi:10.1016/S2213-2600(20)30224-1
  • Sungnak W, Huang N, Becavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–687. doi:10.1038/s41591-020-0868-6
  • Ciulla MM. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs. Hypertens Res. 2020;43(9):985–986. doi:10.1038/s41440-020-0488-z
  • Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141(23):1930–1936. doi:10.1161/CIRCULATIONAHA.120.047164
  • Wang K, Gheblawi M, Oudit GY. Angiotensin converting enzyme 2: a double-edged sword. Circulation. 2020;142(5):426–428. doi:10.1161/CIRCULATIONAHA.120.047049
  • Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810. doi:10.1001/jamacardio.2020.0950
  • Ceravolo MG, Arienti C, de Sire A, et al. Rehabilitation and COVID-19: the cochrane rehabilitation 2020 rapid living systematic review. Eur J Phys Rehabil Med. 2020;56(5):642–651. doi:10.23736/S1973-9087.20.06501-6
  • de Sire A, Andrenelli E, Negrini F, Negrini S, Ceravolo MG. Systematic rapid living review on rehabilitation needs due to COVID-19: update as of April 30th, 2020. Eur J Phys Rehabil Med. 2020;56(3):354–360. doi:10.23736/S1973-9087.20.06378-9
  • Curci C, Pisano F, Bonacci E, et al. Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol. Eur J Phys Rehabil Med. 2020;56(5):633–641. doi:10.23736/S1973-9087.20.06339-X
  • Ferraro F, Calafiore D, Dambruoso F, Guidarini S, de Sire A. COVID-19 related fatigue: which role for rehabilitation in post-COVID-19 patients? A case series. J Med Virol. 2020. doi:10.1002/jmv.26717
  • Salawu A, Green A, Crooks MG, Brixey N, Ross DH, Sivan M. A proposal for multidisciplinary tele-rehabilitation in the assessment and rehabilitation of COVID-19 survivors. Int J Environ Res Public Health. 2020;17(13):4890. doi:10.3390/ijerph17134890
  • Wang TJ, Chau B, Lui M, Lam GT, Lin N, Humbert S. Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehabil. 2020;99(9):769–774. doi:10.1097/PHM.0000000000001505
  • Vitacca M, Carone M, Clini EM, et al. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper. Respiration. 2020;99(6):493–499. doi:10.1159/000508399
  • McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.
  • Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. doi:10.1164/rccm.201309-1634ST
  • Vogiatzis I, Rochester CL, Spruit MA, Troosters T, Clini EM; American Thoracic Society/European Respiratory Society Task Force on Policy in Pulmonary R. Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement. Eur Respir J. 2016;47(5):1336–1341. doi:10.1183/13993003.02151-2015
  • Chen W, Thomas J, Sadatsafavi JM, FitzGerald,JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-6
  • Mannino DM, Higuchi K, Yu TC, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148(1):138–150. doi:10.1378/chest.14-2434
  • Spruit MA, Pitta F, Garvey C, et al. Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J. 2014;43(5):1326–1337. doi:10.1183/09031936.00145613
  • Garvey C, Bayles MP, Hamm LF, et al. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: AN OFFICIAL STATEMENT FROM THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION. J Cardiopulm Rehabil Prev. 2016;36(2):75–83. doi:10.1097/HCR.0000000000000171
  • Alison JA, McKeough ZJ, Johnston K, et al. Australian and New Zealand pulmonary rehabilitation guidelines. Respirology. 2017;22(4):800–819. doi:10.1111/resp.13025
  • Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5 Suppl):4S–42S. doi:10.1378/chest.06-2418
  • Effing TW, Vercoulen JH, Bourbeau J, et al. Definition of a COPD self-management intervention: international Expert Group consensus. Eur Respir J. 2016;48(1):46–54. doi:10.1183/13993003.00025-2016
  • Benzo R, Vickers K, Novotny PJ, et al. Health coaching and chronic obstructive pulmonary disease rehospitalization. A Randomized Study. Am J Respir Crit Care Med. 2016;194(6):672–680. doi:10.1164/rccm.201512-2503OC
  • Benzo R, McEvoy C. Effect of health coaching delivered by a respiratory therapist or nurse on self-management abilities in severe COPD: analysis of a Large Randomized Study. Respir Care. 2019;64(9):1065–1072. doi:10.4187/respcare.05927
  • Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163(5):585–591. doi:10.1001/archinte.163.5.585
  • Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2010;182(7):890–896. doi:10.1164/rccm.200910-1579OC
  • Wadell K, Janaudis Ferreira T, Arne M, Lisspers K, Stallberg B, Emtner M. Hospital-based pulmonary rehabilitation in patients with COPD in Sweden–a national survey. Respir Med. 2013;107(8):1195–1200. doi:10.1016/j.rmed.2013.04.019
  • Thorpe O, Johnston K, Kumar S. Barriers and enablers to physical activity participation in patients with COPD: a systematic review. J Cardiopulm Rehabil Prev. 2012;32(6):359–369. doi:10.1097/HCR.0b013e318262d7df
  • Fan VS, Giardino ND, Blough DK, Kaplan RM, Ramsey SD, Nett Research G. Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD. 2008;5(2):105–116. doi:10.1080/15412550801941190
  • Sabit R, Griffiths TL, Watkins AJ, et al. Predictors of poor attendance at an outpatient pulmonary rehabilitation programme. Respir Med. 2008;102(6):819–824. doi:10.1016/j.rmed.2008.01.019
  • Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis. 2011;8(2):89–99. doi:10.1177/1479972310393756
  • Rochester CL, Vogiatzis I, Holland AE, et al. An Official American Thoracic Society/European Respiratory Society Policy Statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192(11):1373–1386. doi:10.1164/rccm.201510-1966ST
  • Jones SE, Green SA, Clark AL, et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax. 2014;69(2):181–182. doi:10.1136/thoraxjnl-2013-204227
  • Maltais F, Bourbeau J, Shapiro S, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2008;149(12):869–878. doi:10.7326/0003-4819-149-12-200812160-00006
  • Güell MR, de Lucas P, Gáldiz JB, et al. Home vs hospital-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a Spanish multicenter trial. Arch Bronconeumol. 2008;44(10):512–518. doi:10.1157/13126830
  • Fernández AM, Pascual J, Ferrando C, Arnal A, Vergara I, Sevila V. Home-based pulmonary rehabilitation in very severe COPD: is it safe and useful? J Cardiopulm Rehabil Prev. 2009;29(5):325–331. doi:10.1097/HCR.0b013e3181ac7b9d
  • Burkow TM, Vognild LK, Johnsen E, et al. Comprehensive pulmonary rehabilitation in home-based online groups: a mixed method pilot study in COPD. BMC Res Notes. 2015;8:766. doi:10.1186/s13104-015-1713-8
  • Holland AE, Mahal A, Hill CJ, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax. 2017;72(1):57–65. doi:10.1136/thoraxjnl-2016-208514
  • Bourbeau J, Gagnon S, Ross B. Pulmonary rehabilitation. Clin Chest Med. 2020;41(3):513–528. doi:10.1016/j.ccm.2020.06.003
  • Turolla A, Rossettini G, Viceconti A, Palese A, Geri T. Musculoskeletal physical therapy during the COVID-19 pandemic: is telerehabilitation the answer? Phys Ther. 2020;100(8):1260–1264. doi:10.1093/ptj/pzaa093
  • Sivan M, Halpin S, Hollingworth L, Snook N, Hickman K, Clifton IJ. Development of an integrated rehabilitation pathway for individuals recovering from COVID-19 in the community. J Rehabil Med. 2020;52(8):jrm00089. doi:10.2340/16501977-2727
  • Kairy D, Lehoux P, Vincent C, Visintin M. A systematic review of clinical outcomes, clinical process, healthcare utilization and costs associated with telerehabilitation. Disabil Rehabil. 2009;31(6):427–447. doi:10.1080/09638280802062553
  • Prvu Bettger JRL. Telerehabilitation in the age of COVID-19: an opportunity for learning health system research. Phys Ther. 2020;100(11):1913–1916. doi:10.1093/ptj/pzaa151
  • Cox NS, McDonald CF, Hill CJ, et al. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2018;2018(6):CD013040.
  • Finkelstein J, Jeong IC, Doerstling M, Shen Y, Wei C, Karpatkin H. Usability of remote assessment of exercise capacity for pulmonary telerehabilitation program. Stud Health Technol Inform. 2020;275:72–76. doi:10.3233/SHTI200697
  • Sarsak HI. Telerehabilitation services: a successful paradigm for occupational therapy clinical services? Int Phys Med Rehabil J. 2020;5(2):93–98.
  • Burns RB, Crislip D, Daviou P, et al. Using telerehabilitation to support assistive technology. Assist Technol. 1998;10(2):126–133. doi:10.1080/10400435.1998.10131970
  • Peretti A, Amenta F, Tayebati SK, Nittari G, Mahdi SS. Telerehabilitation: review of the state-of-the-art and areas of application. JMIR Rehabil Assist Technol. 2017;4(2):e7. doi:10.2196/rehab.7511
  • Tabak M, Vollenbroek-Hutten MM, van der Valk PD, van der Palen J, Hermens HJ. A telerehabilitation intervention for patients with Chronic Obstructive Pulmonary Disease: a randomized controlled pilot trial. Clin Rehabil. 2014;28(6):582–591. doi:10.1177/0269215513512495
  • Tabak M, Brusse-Keizer M, van der Valk P, Hermens H, Vollenbroek-Hutten M. A telehealth program for self-management of COPD exacerbations and promotion of an active lifestyle: a pilot randomized controlled trial. Int J Chron Obstruct Pulmon Dis. 2014;9:935–944. doi:10.2147/COPD.S60179
  • Paneroni M, Colombo F, Papalia A, et al. Is telerehabilitation a safe and viable option for patients with COPD? A feasibility study. COPD. 2015;12(2):217–225. doi:10.3109/15412555.2014.933794
  • Zanaboni P, Lien LA, Hjalmarsen A, Wootton R. Long-term telerehabilitation of COPD patients in their homes: interim results from a pilot study in Northern Norway. J Telemed Telecare. 2013;19(7):425–429. doi:10.1177/1357633X13506514
  • Holland AE, Hill CJ, Rochford P, Fiore J, Berlowitz DJ, McDonald CF. Telerehabilitation for people with chronic obstructive pulmonary disease: feasibility of a simple, real time model of supervised exercise training. J Telemed Telecare. 2013;19(4):222–226. doi:10.1177/1357633x13487100
  • Marquis N, Larivée P, Saey D, Dubois M, Tousignant M. In-home pulmonary telerehabilitation for patients with chronic obstructive pulmonary disease: a pre-experimental study on effectiveness, satisfaction, and adherence. Telemed J E Health. 2015;21(11):870–879. doi:10.1089/tmj.2014.0198
  • Tousignant M, Marquis N, Pagé C, et al. In-home telerehabilitation for older persons with chronic obstructive pulmonary disease: a Pilot Study. Int J Telerehabil. 2012;4(1):7–14. doi:10.5195/IJT.2012.6083
  • Tsai LL, McNamara RJ, Moddel C, Alison JA, McKenzie DK, McKeough ZJ. Home-based telerehabilitation via real-time videoconferencing improves endurance exercise capacity in patients with COPD: the randomized controlled TeleR Study. Respirology. 2017;22(4):699–707. doi:10.1111/resp.12966
  • Hansen H, Bieler T, Beyer N, et al. Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: a randomised multicentre trial. Thorax. 2020;75(5):413–421. doi:10.1136/thoraxjnl-2019-214246
  • Barbosa MT, Sousa CS, Morais-Almeida M, Simoes MJ, Mendes P. Telemedicine in COPD: an Overview by Topics. COPD. 2020;17(5):601–617. doi:10.1080/15412555.2020.1815182
  • Cox NS, McDonald CF, Alison JA, et al. Telerehabilitation versus traditional centre-based pulmonary rehabilitation for people with chronic respiratory disease: protocol for a randomised controlled trial. BMC Pulm Med. 2018;18(1):71. doi:10.1186/s12890-018-0646-0
  • Stickland M, Jourdain T, Wong EY, Rodgers WM, Jendzjowsky NG, MacDonald,GF. Using Telehealth technology to deliver pulmonary rehabilitation to patients with chronic obstructive pulmonary disease. Can Respir J. 2011;18(4):216–220. doi:10.1155/2011/640865
  • Holland AE, Cox NS. Telerehabilitation for COPD: could pulmonary rehabilitation deliver on its promise? Respirology. 2017;22(4):626–627. doi:10.1111/resp.13028
  • Centers for Medicare and Medicaid Services. COVID-19 emergency declaration blanket waivers for health care providers 2020; [Internet]. Available from: https://www.cms.gov/files/document/summary-covid-19-emergency-declaration-waivers.pdf. Accessed November 9, 2020.
  • Impact of COVID-19 on the physical therapy profession: a report from the American Physical Therapy Association. [Internet]. Available from: https://www.naranet.org/uploads/userfiles/files/documents/APTAReportImpactOfCOVID-19OnThePhysicalTherapyProfession.pdf. Accessed November 6, 2020.
  • Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941. doi:10.1016/j.rmed.2020.105941
  • Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol. 2020;92(10):1915–1921. doi:10.1002/jmv.25889
  • Dechman G, Aceron R, Beauchamp M et al. Delivering pulmonary rehabilitation during the COVID-19 pandemic: a Canadian Thoracic Society Position Statement. Available from: https://www.tandfonline.com/doi/full/10.1080/24745332.2020.1828683. Accessed February 11, 2021.
  • Garvey C, Singer JP, Bruun AM, Soong A, Rigler J, Hays S. Moving Pulmonary Rehabilitation Into the Home: A CLINICAL REVIEW. J Cardiopulm Rehabil Prev. 2018;38(1):8–16. doi:10.1097/HCR.0000000000000287
  • Gonzalez-Gerez JJ, Bernal-Utrera C, Anarte-Lazo E, Garcia-Vidal JA, Botella-Rico JM, Rodriguez-Blanco C. Therapeutic pulmonary telerehabilitation protocol for patients affected by COVID-19, confined to their homes: study protocol for a randomized controlled trial. Trials. 2020;21(1):588. doi:10.1186/s13063-020-04494-w
  • Bierman RT, Kwong MW, Calouro C. State occupational and physical therapy telehealth laws and regulations: a 50-state survey. Int J Telerehabil. 2018;10(2):3–54. doi:10.5195/IJT.2018.6269
  • Ambrosino N, Fracchia C. The role of tele-medicine in patients with respiratory diseases. Expert Rev Respir Med. 2017;11(11):893–900. doi:10.1080/17476348.2017.1383898
  • Bentley CL, Powell L, Potter S, et al. The use of a smartphone app and an activity tracker to promote physical activity in the management of chronic obstructive pulmonary disease: randomized Controlled Feasibility Study. JMIR mHealth uHealth. 2020;8(6):e16203. doi:10.2196/16203